Compliance Feasibility Study for Remote Phase 2 Cardiac Rehabilitation
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03491982 |
|
Recruitment Status :
Completed
First Posted : April 9, 2018
Last Update Posted : November 1, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Referred by Cardiologist for Phase 2 Cardiac Rehabilitation | Device: Remote Cardiac Rehab | Not Applicable |
In spite of the fact that cardiac rehabilitation has been shown to be beneficial to patients who have had a cardiac event, such as a heart attack, only 5% of eligible patients complete this program. Some of the reasons cited include limited facility access, travel time and cost.
We are testing the hypothesis that cardiac rehab compliance will be greater if patients are offered the opportunity, and associated technology, to perform cardiac rehab anywhere.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 25 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Health Services Research |
| Official Title: | Compliance Feasibility Study for Remote Phase 2 Cardiac Rehabilitation |
| Actual Study Start Date : | March 19, 2018 |
| Actual Primary Completion Date : | September 30, 2019 |
| Actual Study Completion Date : | September 30, 2019 |
- Device: Remote Cardiac Rehab
Remote Cardiac Rehab
- Percentage of patients completing remote rehab program compared to case controls [ Time Frame: Immediately after cardiac rehab completion or stoppage ]
- Six minute walk test compared to case controls [ Time Frame: Immediately after cardiac rehab completion or stoppage ]
- depression score vs case controls [ Time Frame: Immediately after cardiac rehab completion or stoppage ]
- Average number of minutes in exercise rehab compared to case controls [ Time Frame: Immediately after cardiac rehab completion or stoppage ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 90 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- referred to SLU cardiac rehab facility
Exclusion Criteria:
- does not own app compatible smart phone
- dementia
- syncope
- valvular disease
- life expectancy < 1 year
- non-English speaking
- unstable angina
- decompensated congestive heart failure
- ventricular arrhythmia
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03491982
| United States, Missouri | |
| Saint Louis University - SLUCare | |
| Saint Louis, Missouri, United States, 63117 | |
| Principal Investigator: | Lisa Alderson, MD | St. Louis University |
| Responsible Party: | Lisa Alderson MD, F.A.C.C., Assistant Professor, St. Louis University |
| ClinicalTrials.gov Identifier: | NCT03491982 |
| Other Study ID Numbers: |
28544 |
| First Posted: | April 9, 2018 Key Record Dates |
| Last Update Posted: | November 1, 2019 |
| Last Verified: | October 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Plan Description: | no current plan |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Cardiac Rehabilitation |

